Autacoids And Related Drug Global Market Report 2025
상품코드:1760473
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 175 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
오타코이드 및 관련 약물 시장 규모는 향후 몇 년간 강력한 성장이 예상됩니다. 2029년에는 6.1%의 연평균 성장률(CAGR)로 성장하여, 676억 4,000만 달러로 성장할 것으로 예상됩니다. 예측 기간 동안의 성장은 노인 인구 증가, 만성 호흡기 질환 유병률 증가, 맞춤형 의료 채택, 신흥 국가의 건강 관리 접근 확대, 심혈관 장애 발생률 증가 등 여러 요인에 기인하고 있습니다. 이 기간의 주요 동향으로는 신약에 있어서의 인공지능의 통합, 이중작용 오타코이드의약품의 개발, 오타코이드 치료에의 바이오시밀러 채택, 셀프메디케이션과 일반용의약품(OTC)의 성장, 의약품제제에 있어서의 나노기술의 이용 등이 있습니다.
심혈관 질환의 유병률 증가는 향후 몇 년 동안 오타코이드 및 관련 약물 시장의 확대를 촉진할 것으로 예측됩니다. 다양한 질병이 포함됩니다. 심혈관 질환 증가는 주로 식생활의 혼란과 관련이 있으며, 포화 지방, 트랜스 지방, 첨가 당, 나트륨의 다량 섭취는 고혈압, 비만, 콜레스테롤 수치 상승의 원인이 됩니다. 그리고 이들은 모두 심장과 관련된 질병의 심각한 위험 요인입니다. 일산화질소, 엔도텔린, 프로스타사이클린이 관여하는 경로를 표적으로 하는 약제는 내피 기능의 회복, 혈관 확장의 촉진, 혈관 저항의 감소를 돕습니다. 2023년 12월 호주 보건복지연구원은 호주에서 관상동맥성 심장병(CHD)에 의한 의사 인증의 사망자 수가 2021년 1만 4,100명에서 2022년에는 1만 4,900명으로 증가했다고 보고했습니다.
자가면역약 및 관련약 시장의 주요 기업은 치료효과를 높이고, 부작용을 줄이고, 보다 정확하고 안전하게 새로운 알레르기성 질환이나 염증성 질환에 대처하기 위해 항히스타민제 등의 혁신적인 제품 개발에 집중하고 있습니다. 항히스타민제는 알레르기 반응시 면역계에서 방출되는 화학물질인 히스타민의 작용을 저해하는 약입니다. Pharmaceuticals는 빌라스틴을 일반용 의약품으로서 독일에서 출시했습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 오타코이드 및 관련 약물의 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 오타코이드 및 관련 약물 시장 : 성장률 분석
세계의 오타코이드 및 관련 약물 시장 실적 : 규모와 성장, 2019-2024년
세계의 오타코이드 및 관련 약물 시장 예측 : 규모와 성장, 2024-2029년, 2034년
세계의 오타코이드 및 관련 약물 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 오타코이드 및 관련 약물 시장 : 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
히스타민
프로스타글란딘
로이코트리엔
세로토닌
브라지키닌
세계의 오타코이드 및 관련 약물 시장 : 투여 방법별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
경구
주사
국소
비강내
흡입
세계의 오타코이드 및 관련 약물 시장 : 용도별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
심혈관 질환
염증성 질환
호흡기 질환
알레르기
위장 장애
세계의 오타코이드 및 관련 약물 시장 : 최종 사용자별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
병원
클리닉
홈케어
약국
세계의 오타코이드 및 관련 약물 시장 : 히스타민 세분화 : 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
H1 수용체 길항제
H2 수용체 길항제
H3 수용체 길항제
H4 수용체 길항제
히스타민 작용제
세계의 오타코이드 및 관련 약물 시장 : 프로스타글란딘 세분화: 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
프로스타글란딘 E1(PGE1) 유사체
프로스타글란딘 E2(PGE2) 유사체
프로스타글란딘 F2a(PGF2a) 유사체
프로스타글란딘 I2(PGI2) 유사체
프로스타글란딘 D2(PGD2) 유사체
세계의 오타코이드 및 관련 약물 시장 : 류코트리엔 세분화: 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
류코트리엔 수용체 길항제(LTRA)
5-리폭시게나제 억제제
류코트리엔 합성 억제제
세계의 오타코이드 및 관련 약물 시장 : 세로토닌 세분화: 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
5-HT1 수용체 작용제
5-HT2 수용체 길항제
5-HT3 수용체 길항제
5-HT4 수용체 작용제
5-HT6 및 5-HT7 조절제
세계의 오타코이드 및 관련 약물 시장 : 브라지키닌 세분화: 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
브라지키닌 B1 수용체 길항제
브라지키닌 B2 수용체 길항제
브라지키닌 수용체 작용제
제7장 지역별/국가별 분석
세계의 오타코이드 및 관련 약물 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
세계의 오타코이드 및 관련 약물 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
오타코이드 및 관련 약물 시장 : 경쟁 구도
오타코이드 및 관련 약물 시장 : 기업 프로파일
Sanofi SA : 개요, 제품 및 서비스, 전략 및 재무 분석
Fresenius SE & Co. KGaA : 개요, 제품 및 서비스, 전략 및 재무 분석
Dr. Reddy's Laboratories Limited : 개요, 제품 및 서비스, 전략 및 재무 분석
EUROAPI SA : 개요, 제품 및 서비스, 전략 및 재무 분석
Pfizer CentreOne : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Cayman Chemical Company
Tokyo Chemical Industry Co. Ltd.
Avanti Polar Lipids Inc.
Kyowa Pharma Chemical Co. Ltd.
Nicox SA
Glentham Life Sciences Ltd.
LGM Pharma Inc.
chemBlink Inc.
ZellBio GmbH
AquigenBio LLC
BOC Sciences Inc.
Yarrow Chem Products Pvt. Ltd.
LEBSA SA
VDK NaturaSyn SA
Enzo Life Sciences Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
오타코이드 및 관련 약물 시장 2029년 : 새로운 기회를 제공하는 국가
오타코이드 및 관련 약물 시장 2029년 : 새로운 기회를 제공하는 부문
오타코이드 및 관련 약물 시장 2029년 : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
SHW
영문 목차
영문목차
Autacoids and related drugs are biologically active substances produced by the body that regulate physiological functions locally, typically within specific tissues or organs. They play a role in inflammation, smooth muscle contraction, immune responses, and the regulation of blood flow. Autacoids exert their effects by binding to specific receptors on target cells, triggering signaling pathways that influence cellular activity.
The main types of autacoids and related drugs include histamines, prostaglandins, leukotrienes, serotonin, and bradykinin. Histamines are chemicals released during allergic reactions that lead to symptoms such as itching, swelling, and increased stomach acid. They are targeted in treatments for allergies and acid-related conditions. Drugs aimed at these autacoids can be administered through various routes, such as oral, injectable, topical, intranasal, and inhalation. These treatments are used for a range of applications, including cardiovascular disorders, inflammatory diseases, respiratory disorders, allergies, and gastrointestinal conditions. The primary end users of these treatments include hospitals, clinics, homecare settings, and pharmacies.
The autacoids and related drug market research report is one of a series of new reports from The Business Research Company that provides autacoids and related drug market statistics, including the autacoids and related drug industry global market size, regional shares, competitors with the autacoids and related drug market share, detailed autacoids and related drug market segments, market trends, and opportunities, and any further data you may need to thrive in the autacoids and related drug industry. This autacoids and related drug market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The autacoids and related drug market size has grown strongly in recent years. It will grow from $50.15 billion in 2024 to $53.32 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth during the historic period can be attributed to several factors, including the increasing prevalence of inflammatory diseases, a rising use of prostaglandins in obstetrics, widespread prescription of antihistamines, the expanding applications of serotonin agonists, and higher demand for migraine relief medications.
The autacoids and related drug market size is expected to see strong growth in the next few years. It will grow to $67.64 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth during the forecast period can be attributed to several factors, including the rising geriatric population, growing prevalence of chronic respiratory diseases, adoption of personalized medicine, expanding healthcare access in emerging economies, and the increasing incidence of cardiovascular disorders. Key trends during this period include the integration of artificial intelligence in drug discovery, the development of dual-action autacoid drugs, the adoption of biosimilars for autacoid treatments, growth in self-medication and over-the-counter (OTC) products, and the use of nanotechnology in drug formulation.
The growing prevalence of cardiovascular diseases is expected to drive the expansion of the autacoids and related drugs market in the coming years. Cardiovascular diseases encompass a range of disorders that impact the heart and blood vessels, including coronary heart disease, heart failure, stroke, and hypertension. The rise in cardiovascular diseases is mainly linked to poor dietary habits, with high consumption of saturated fats, trans fats, added sugars, and sodium contributing to high blood pressure, obesity, and elevated cholesterol levels, all of which are significant risk factors for heart-related conditions. Autacoids and related drugs support cardiovascular health by modulating vascular tone and inflammation, both of which are critical in managing hypertension and heart failure. Agents that target pathways involving nitric oxide, endothelin, and prostacyclin aid in restoring endothelial function, promoting vasodilation, and reducing vascular resistance. For instance, in December 2023, the Australian Institute of Health and Welfare reported that the number of doctor-certified deaths due to coronary heart disease (CHD) in Australia rose from 14,100 in 2021 to 14,900 in 2022. Consequently, the increasing prevalence of cardiovascular diseases is fueling the growth of the autacoids and related drugs market.
Leading companies in the autacoids and related drugs market are concentrating on the development of innovative products, such as antihistamines, to enhance therapeutic effectiveness, reduce side effects, and address new allergic and inflammatory conditions with greater accuracy and safety. Antihistamines are medications that block the effects of histamine, a chemical released by the immune system during an allergic reaction. For example, in March 2023, Tiefenbacher Pharmaceuticals, a Germany-based pharmaceutical company, launched Bilastine as an over-the-counter (OTC) medication in Germany, representing a significant advancement in improving access to effective allergy treatments. The 20 mg Bilastine tablets offer a non-sedating, second-generation antihistamine solution for individuals experiencing allergic symptoms such as hay fever and urticaria.
In May 2024, Incyte Corporation, a US-based biopharmaceutical company, completed the acquisition of Escient Pharmaceuticals Inc. for approximately $750 million. This acquisition enables Incyte to expand its immunology portfolio and accelerate the development of novel treatments for pruritus and other inflammatory disorders by integrating Escient Pharmaceuticals' innovative pipeline of first-in-class, small molecule therapeutics targeting Mas-related G protein-coupled receptors (MRGPRs). Escient Pharmaceuticals Inc., a US-based biotechnology company, is focused on developing novel therapeutics that target autacoid-related pathways.
Major players in the autacoids and related drug market are Sanofi S.A., Fresenius SE & Co. KGaA, Dr. Reddy's Laboratories Limited, EUROAPI S.A., Pfizer CentreOne, Cayman Chemical Company, Tokyo Chemical Industry Co. Ltd., Avanti Polar Lipids Inc., Kyowa Pharma Chemical Co. Ltd., Nicox S.A., Glentham Life Sciences Ltd., LGM Pharma Inc., chemBlink Inc., ZellBio GmbH, AquigenBio LLC, BOC Sciences Inc., Yarrow Chem Products Pvt. Ltd., LEBSA S.A., VDK NaturaSyn S.A., Enzo Life Sciences Inc.
North America was the largest region in the autacoids and related drug market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in autacoids and related drug report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the autacoids and related drugsmarket report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The autacoids and related drug market consists of sales of biogenic amines, polypeptide autacoids, lipid-derived autacoids, and leukotrienes. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Autacoids And Related Drug Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on autacoids and related drug market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for autacoids and related drug ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The autacoids and related drug market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Histamines; Prostaglandins; Leukotrienes; Serotonin; Bradykinin
2) By Administration: Oral; Injectable; Topical; Intranasal; Inhalation
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Autacoids And Related Drug Market Characteristics
3. Autacoids And Related Drug Market Trends And Strategies
4. Autacoids And Related Drug Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Autacoids And Related Drug Growth Analysis And Strategic Analysis Framework
5.1. Global Autacoids And Related Drug PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Autacoids And Related Drug Market Growth Rate Analysis
5.4. Global Autacoids And Related Drug Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Autacoids And Related Drug Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Autacoids And Related Drug Total Addressable Market (TAM)
6. Autacoids And Related Drug Market Segmentation
6.1. Global Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Histamines
Prostaglandins
Leukotrienes
Serotonin
Bradykinin
6.2. Global Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Injectable
Topical
Intranasal
Inhalation
6.3. Global Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cardiovascular Disorders
Inflammatory Diseases
Respiratory Disorders
Allergies
Gastrointestinal Disorders
6.4. Global Autacoids And Related Drug Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Homecare
Pharmacies
6.5. Global Autacoids And Related Drug Market, Sub-Segmentation Of Histamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
H1 Receptor Antagonists
H2 Receptor Antagonists
H3 Receptor Antagonists
H4 Receptor Antagonists
Histamine Agonists
6.6. Global Autacoids And Related Drug Market, Sub-Segmentation Of Prostaglandins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Prostaglandin E1 (PGE1) Analogs
Prostaglandin E2 (PGE2) Analogs
Prostaglandin F2a (PGF2a) Analogs
Prostaglandin I2 (PGI2) Analogs
Prostaglandin D2 (PGD2) Analogs
6.7. Global Autacoids And Related Drug Market, Sub-Segmentation Of Leukotrienes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Leukotriene Receptor Antagonists (LTRAs)
5-Lipoxygenase Inhibitors
Leukotriene Synthesis Inhibitors
6.8. Global Autacoids And Related Drug Market, Sub-Segmentation Of Serotonin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
5-HT1 Receptor Agonists
5-HT2 Receptor Antagonists
5-HT3 Receptor Antagonists
5-HT4 Receptor Agonists
5-HT6 And 5-HT7 Modulators
6.9. Global Autacoids And Related Drug Market, Sub-Segmentation Of Bradykinin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bradykinin B1 Receptor Antagonists
Bradykinin B2 Receptor Antagonists
Bradykinin Receptor Agonists
7. Autacoids And Related Drug Market Regional And Country Analysis
7.1. Global Autacoids And Related Drug Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Autacoids And Related Drug Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Autacoids And Related Drug Market
8.1. Asia-Pacific Autacoids And Related Drug Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Autacoids And Related Drug Market
9.1. China Autacoids And Related Drug Market Overview
9.2. China Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Autacoids And Related Drug Market
10.1. India Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Autacoids And Related Drug Market
11.1. Japan Autacoids And Related Drug Market Overview
11.2. Japan Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Autacoids And Related Drug Market
12.1. Australia Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Autacoids And Related Drug Market
13.1. Indonesia Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Autacoids And Related Drug Market
14.1. South Korea Autacoids And Related Drug Market Overview
14.2. South Korea Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Autacoids And Related Drug Market
15.1. Western Europe Autacoids And Related Drug Market Overview
15.2. Western Europe Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Autacoids And Related Drug Market
16.1. UK Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Autacoids And Related Drug Market
17.1. Germany Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Autacoids And Related Drug Market
18.1. France Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Autacoids And Related Drug Market
19.1. Italy Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Autacoids And Related Drug Market
20.1. Spain Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Autacoids And Related Drug Market
21.1. Eastern Europe Autacoids And Related Drug Market Overview
21.2. Eastern Europe Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Autacoids And Related Drug Market
22.1. Russia Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Autacoids And Related Drug Market
23.1. North America Autacoids And Related Drug Market Overview
23.2. North America Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Autacoids And Related Drug Market
24.1. USA Autacoids And Related Drug Market Overview
24.2. USA Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Autacoids And Related Drug Market
25.1. Canada Autacoids And Related Drug Market Overview
25.2. Canada Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Autacoids And Related Drug Market
26.1. South America Autacoids And Related Drug Market Overview
26.2. South America Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Autacoids And Related Drug Market
27.1. Brazil Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Autacoids And Related Drug Market
28.1. Middle East Autacoids And Related Drug Market Overview
28.2. Middle East Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Autacoids And Related Drug Market
29.1. Africa Autacoids And Related Drug Market Overview
29.2. Africa Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Autacoids And Related Drug Market Competitive Landscape And Company Profiles
30.1. Autacoids And Related Drug Market Competitive Landscape
30.2. Autacoids And Related Drug Market Company Profiles
30.2.1. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Fresenius SE & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Dr. Reddy's Laboratories Limited Overview, Products and Services, Strategy and Financial Analysis
30.2.4. EUROAPI S.A. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Pfizer CentreOne Overview, Products and Services, Strategy and Financial Analysis
31. Autacoids And Related Drug Market Other Major And Innovative Companies
31.1. Cayman Chemical Company
31.2. Tokyo Chemical Industry Co. Ltd.
31.3. Avanti Polar Lipids Inc.
31.4. Kyowa Pharma Chemical Co. Ltd.
31.5. Nicox S.A.
31.6. Glentham Life Sciences Ltd.
31.7. LGM Pharma Inc.
31.8. chemBlink Inc.
31.9. ZellBio GmbH
31.10. AquigenBio LLC
31.11. BOC Sciences Inc.
31.12. Yarrow Chem Products Pvt. Ltd.
31.13. LEBSA S.A.
31.14. VDK NaturaSyn S.A.
31.15. Enzo Life Sciences Inc.
32. Global Autacoids And Related Drug Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Autacoids And Related Drug Market
34. Recent Developments In The Autacoids And Related Drug Market
35. Autacoids And Related Drug Market High Potential Countries, Segments and Strategies
35.1 Autacoids And Related Drug Market In 2029 - Countries Offering Most New Opportunities
35.2 Autacoids And Related Drug Market In 2029 - Segments Offering Most New Opportunities
35.3 Autacoids And Related Drug Market In 2029 - Growth Strategies
